Squamous Cell Carcinoma (SCC) or Squamous Cell Carcinoma in Situ (Bowen's Disease)
A scaly 1.5 cm papule that intermittently bleeds on a flexor surface most commonly describes squamous cell carcinoma (SCC) or its precursor, squamous cell carcinoma in situ (Bowen's disease), and requires excisional biopsy for definitive diagnosis and treatment.
Clinical Reasoning
The key clinical features pointing to this diagnosis are:
Intermittent bleeding - This is a critical red flag feature that distinguishes malignant/premalignant lesions from benign conditions. Bleeding is specifically listed as a minor criterion for concerning lesions in melanoma guidelines 1, and the same principle applies to non-melanoma skin cancers.
Scale on a papule - While this creates a papulosquamous appearance, the combination with bleeding strongly suggests malignancy rather than benign papulosquamous diseases like psoriasis or lichen planus.
Size of 1.5 cm - This substantial size increases concern for SCC, as actinic keratoses (the precursor lesion) are typically smaller.
Flexor surface location - While less common than sun-exposed extensor surfaces, SCC can occur on flexor surfaces, particularly in the context of chronic inflammation or other risk factors.
Differential Diagnosis Considerations
While the provided evidence focuses heavily on melanoma, actinic keratosis, and Bowen's disease, the clinical presentation described does not fit melanoma (which would be pigmented and follow ABCDE criteria 1).
Why not actinic keratosis? Actinic keratoses are typically smaller, rough, scaly patches that may bleed with trauma, but intermittent spontaneous bleeding in a 1.5 cm lesion suggests progression to invasive SCC 2.
Why not benign papulosquamous disease? Conditions like psoriasis, lichen planus, or pityriasis rosea 3, 4 can present with scaly papules on flexor surfaces, but intermittent bleeding is not characteristic and should raise immediate concern for malignancy.
Immediate Management Algorithm
Perform excisional biopsy with 2-4 mm margins - This is the gold standard for diagnosis 1, 5. The guidelines emphasize that cutaneous lesions should be excised rather than biopsied to avoid misdiagnosis and allow complete histological assessment 1.
Orient the excision longitudinally along the flexor surface to facilitate potential re-excision if margins are positive 1.
Send for standard histopathological examination - Avoid frozen sections 1. Request assessment of:
- Depth of invasion (if SCC)
- Margin clearance
- Presence of perineural invasion 6
Document the clinical appearance with photography and precise measurements before excision.
Critical Pitfalls to Avoid
Do not use destructive methods (cryotherapy, laser, electrocautery) for initial diagnosis when malignancy is suspected, as this compromises histological assessment 1.
Do not perform punch biopsy alone - A 1.5 cm bleeding lesion requires complete excision for accurate diagnosis and may represent the definitive treatment if margins are clear 5.
Do not delay - Intermittent bleeding in a scaly lesion is a red flag requiring urgent evaluation through a 2-week cancer pathway 2.
Post-Diagnosis Management
If histology confirms SCC in situ (Bowen's disease): The excision may be curative if margins are clear. Alternative treatments include PDT, 5-fluorouracil, or imiquimod for lesions not amenable to surgery 5.
If histology confirms invasive SCC: Re-excision with wider margins (4-6 mm for low-risk lesions) is required 6. Consider adjuvant radiotherapy if extensive perineural involvement is present 6.
The combination of scale, size, and intermittent bleeding makes this a high-risk lesion requiring immediate excisional biopsy rather than observation or topical therapy.